Moll Wenden advised Scandinavian ChemoTech AB on the deal.Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical technology…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Maha Kanaan
…
This content is for Standard 1 Year members only. LoginJoin Now